Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Join us on Tuesday 4 June for an exclusive drinks reception and panel event featuring some of the UK’s top former and current sports professionals living with type 1 diabetes.
Find out about the latest progress in type 1 diabetes research, learn more about our ongoing partnerships or see what our celebrity ambassadors are up to.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D. Every pound raised directly supports us to fund our life-changing research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > Type 1 Diabetes Grand Challenge invests £5 million to kick off the race towards a cure
Dr Victoria Salem at Imperial College London
We’re excited to reveal the first research projects funded by the Type 1 Diabetes Grand Challenge, our partnership with the Steve Morgan Foundation and Diabetes UK.
£5 million will support a trio of exceptional scientists to develop new and improved treatments for type 1 diabetes and marks the start of a £50 million programme of research, made possible by the Steve Morgan Foundation’s landmark investment.
The funding goes to scientists in different corners of the UK, who will each solve different problems to help propel us towards a cure.
Dr James Cantley, at the University of Dundee, will develop new drugs to help people with type 1 diabetes grow back their own beta cells inside their pancreas. This approach could avoid problems with the immune system rejecting transplanted ‘foreign’ donor or lab-made beta cells and allow the pancreas to produce its own insulin again.
Dr Cantley said, “Regenerating beta cells in the pancreas has the potential to revolutionise the treatment of type 1 diabetes, by replacing cells destroyed by the immune attack, and ultimately leading to stable blood sugar levels and a life free from insulin injections.”
Dr Victoria Salem, at Imperial College London, will use state-of-the-art 3D bioprinting to ‘print’ a device that can be implanted into people with type 1 diabetes to deliver a new supply of beta cells.
The device will act as a barrier and protect the beta cells sitting inside, by blocking attacking immune cells, while still letting in vital nutrients they need to survive.
Dr Salem said, “The dream for a cell cased cure for type 1 diabetes is now tantalisingly close – I’m so excited and honoured to be a part of this journey.”
Professor Sarah Richardson, at the University of Exeter, will probe how and why a person’s immune system destroys their own beta cells and how this process may differ between people with type 1 diabetes. She’ll also study how beta cells can fight back against the immune attack.
With this knowledge, scientists could develop an armoury of new treatments that target different lines of the immune system’s attack.
Professor Richardson said, “Ultimately, this will help us tailor existing and emerging therapies to the individual, maximising the benefits for people with type 1 diabetes.”
Read more about the Grand Challenge researchers’ plans on the Type 1 Diabetes Grand Challenge website.
Read our top takeaways from the ‘Recruiting to medical research programmes and trials – how can we be smarter and more equitable?’ webinar.
Researchers funded by Breakthrough T1D in the US have published promising new data that could help to improve islet transplantation for people with T1D.
A new paper co-authored by Breakthrough T1D, Diabetes UK, and Kidney Research UK has identified six themes to tackle diabetic kidney disease.
Sana Biotechnology, a US-based biotech company, has released clinical data showing that the first person receiving engineered islets from deceased donors is now producing insulin without the need for immunosuppressive drugs.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
